For example, recently widely used Sodium-Glucose Co-Transport 2 (SGLT2) inhibitors and Glucagon-Like Peptide-1 (GLP-1) receptor agonists have been highly successful in the treatment of diabetes, with an additionally established positive effect on left ventricle function after ACS [52]. Here, SLC5A2 is linked to diabetes mellitus.